To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

NCT05760781 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped The preliminary effectiveness data observed at present did not meet the expectations, the benefit of the subjects receiving the experimental drug was limited.

Conditions

Interventions

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Collaborators